Dissolved and financials
CVR: 37175439
Not available
Net result: DKK 0
No owners listed
CVR · view owners
No management registered
CVR · view management
Dissolved
Ceased 6 May 2022
CVR · view overview
No headcount reported
Director role ended: Hussein Nasser Awada
CVR · 06/05/2022
View the full event history
NucliRay Defence IVS was a Danish company of the type Iværksætterselskab based in København K, founded in 2015. The company has been dissolved on 6 May 2022. The company was registered under the industry Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik. In 2020, the company reported a net result of DKK 0 compared with DKK -1,896 the year before. Equity in the 2020 report amounted to DKK 68,133.
Source: annual reports filed with the Danish Business Authority.
| Period | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202001/01/2020 – 31/12/2020 | - | 0 | 68 t. | 68 t. | - | |
| 201901/01/2019 – 31/12/2019 | 0 | -2 t. | 68 t. | 68 t. | - | |
| 201801/01/2018 – 31/12/2018 | 0 | -4 t. | 70 t. | 70 t. | - | |
| 201701/01/2017 – 31/12/2017 | 0 | -61 t. | 65 t. | 65 t. | - | |
| 201601/01/2016 – 31/12/2016 | 0 | -133 t. | 71 t. | 71 t. | - |
Screen owners and management against the Danish FSA's official PEP lists
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningNo. NucliRay Defence IVS is registered in the Danish CVR register with the status Dissolved and ceased on 6 May 2022.
The CVR number of NucliRay Defence IVS is 37175439.
NucliRay Defence IVS was founded on 23 October 2015.
NucliRay Defence IVS was registered under the industry Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik (industry code 721900).
NucliRay Defence IVS was located at c/o Awada, Gothersgade 33A 3. th, 1123 København K.
As of May 6, 2022, Hussein Nasser Awada has stepped down as adm. dir. of NucliRay Defence IVS.
As of May 6, 2022, Mathias Spliid Heltberg has stepped down as director of NucliRay Defence IVS.
NucliRay Defence IVS was dissolved on May 6, 2022.
NucliRay Defence IVS has published its annual report for 2020. The net result was DKK 0.
NucliRay Defence IVS has published its annual report for 2019. Revenue came to DKK 0, and the net result was DKK -1,896.
NucliRay Defence IVS has published its annual report for 2018. Revenue came to DKK 0, and the net result was DKK -3,924.
NucliRay Defence IVS has published its annual report for 2017. Revenue came to DKK 0, and the net result was DKK -61,272.
NucliRay Defence IVS has published its annual report for 2016. Revenue came to DKK 0, and the net result was DKK -132,703.
As of October 1, 2016, Mathias Spliid Heltberg is registered as director of NucliRay Defence IVS.
NucliRay Defence IVS has published its interim report for the period October 23, 2015 – December 31, 2015.
As of May 25, 2016, Ahmad Zakria Gardizi has stepped down as director of NucliRay Defence IVS.
As of October 23, 2015, Hussein Nasser Awada is registered as adm. dir. of NucliRay Defence IVS.
As of October 23, 2015, Ahmad Zakria Gardizi is registered as director of NucliRay Defence IVS.
NucliRay Defence IVS was founded on October 23, 2015.
Uneven Bits ApS is an independent IT consultancy founded and operated by Klaus Byskov Pedersen. With deep expertise in software architecture and systems design, I help organizations build robust, scalable, and maintainable technical solutions. Whether you need strategic guidance on technology decisions, hands-on architecture work, or help navigating complex technical challenges, I bring focused expertise and a practical approach to every engagement.
Selskabets formål er IT- og kommunikationsvirksomhed samt virksomhed i øvrigt, der efter bestyrelsens skøn står i forbindelse hermed.
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
Selskabets formål er at drive forretning med digital markedsføring og strategi samt enhver i forbindelse hermed stående virksomhed.
